HM Payson & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-252
| Closed | -$59.3K | – | 1039 |
|
|
2024
Q4 | $59.3K | Buy |
+252
| New | +$59.3K | ﹤0.01% | 615 |
|
|
2022
Q1 | – | Sell |
-218
| Closed | -$37K | – | 1047 |
|
|
2021
Q4 | $37K | Buy |
+218
| New | +$37K | ﹤0.01% | 663 |
|
|
2021
Q2 | – | Sell |
-465
| Closed | -$66K | – | 1089 |
|
|
2021
Q1 | $66K | Buy |
465
+255
| +121% | +$36.2K | ﹤0.01% | 553 |
|
|
2020
Q4 | $27K | Sell |
210
-52
| -20% | -$6.69K | ﹤0.01% | 714 |
|
|
2020
Q3 | $38K | Buy |
+262
| New | +$38K | ﹤0.01% | 604 |
|